104 results
8-K
EX-10.2
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
26 Sep 23
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
7:04am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
13 Sep 23
Entry into a Material Definitive Agreement
4:03pm
8-K
EX-10.2
AVTX
Avalo Therapeutics Inc
13 Sep 23
Entry into a Material Definitive Agreement
4:03pm
8-K
EX-10.1
1cdm q8w1nn1g3ztwfv1
14 Aug 23
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-10.1
2xj9 w4ge62bst2g0
21 Jul 23
Entry into a Material Definitive Agreement
8:25am
8-K
EX-10.1
gt3u3pwvyh57as5
2 Jun 23
Entry into a Material Definitive Agreement
7:05am
8-K
EX-10.1
jc2uaif87ttoq
11 Aug 22
Avalo Therapeutics Announces Board Changes
4:03pm
8-K
EX-10.2
d62493ha8qiuq
18 Feb 22
Avalo Therapeutics Announces Leadership Transition
4:01pm
8-K
EX-10.1
1vi8ae0d0x81 zcwzf98
18 Feb 22
Avalo Therapeutics Announces Leadership Transition
4:01pm